rfhg_123092.1

Basic information about the TSS

---

TSS ID: rfhg_123092.1 Species: human Chr: chr10		Start: 14838159 End: 14838177 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2317623,EH38E1450531)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC108738:49 GeneID: 51182 HGNC/MGI_ID: HGNC:29526 UniProt_ID: Nearer transcript ids and distances: ENST00000645667.1:125 ENST00000640019.3:129 ENST00000378372.8:129 NM_001378790.1:129 NM_001378785.1:129 NM_016299.4:129 AK302452:139 AK225265:139 AK225651:139 AK000880:142 BC065281:152 BC038845:153 ENST00000493178.1:154 BC119690:164 BC119691:164 AF112210:164 AF143723:173 AK292323:175 KJ902567:225 AB528152:225 AB587406:225 KJ893846:225 ENST00000441647.1:260 view more...

Gene_name: heat shock protein family A (Hsp70) member 14 Gene_symbol: HSPA14 Gene_synonyms: HSP70-4 HSP70L1 Gene_source: HGNC:29526

TATA-Box annotation

---

Distance to TSS:	8
Nearest PromoterID:	NM_001278205
Entrez ID:	51182
Nearest Unigene:	Hs.534169
Nearest Refseq:	NM_016299
Nearest Ensembl:	ENSG00000187522
Gene Name:	heat shock protein family A (Hsp70) member 14
Gene Alias:	HSP70-4|HSP70L1
Gene Type:	protein-coding
CpG%:	0.111111
GC%:	0.578947
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HSPA14 p2@HSPA14 p4@HSPA14 p5@HSPA14 p8@HSPA14
Sample		p1@HSPA14	p2@HSPA14	p4@HSPA14	p5@HSPA14	p8@HSPA14
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	46.17	23.77	8.57	9.74	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	52.60	20.64	6.47	14.36	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	52.08	21.41	9.26	14.85	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	37.84	17.88	10.40	14.35	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	44.77	20.47	12.82	11.47	1.35
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	43.61	24.03	12.99	15.12	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	53.60	34.86	14.82	14.16	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	50.62	29.55	7.51	14.05	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	53.64	23.30	8.98	14.32	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	47.53	46.95	19.13	15.65	3.48
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	40.42	40.02	17.38	16.57	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.09	45.13	19.92	23.58	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.83	1.61	0.16	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.57	0.90	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	13.83	1.76	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.79	2.26	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.74	1.97	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.17	2.11	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	6.93	4.27	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.48	3.01	0.00	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.82	2.27	0.40	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	5.87	2.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	6.85	3.36	0.26	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.95	1.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	10.06	2.84	0.00	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.01	4.11	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	4.40	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.84	4.48	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.43	3.55	0.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.86	2.35	0.00	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.21	3.77	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.62	2.93	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.17	3.59	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	7.59	5.94	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.11	2.24	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.81	2.68	0.00	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.04	3.27	0.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.27	3.02	0.60	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.45	5.40	0.54	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	12.00	5.28	0.48	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	6.35	3.76	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	7.61	4.39	0.44	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.60	3.16	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.92	3.67	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.83	3.41	0.20	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.91	2.56	0.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.32	1.92	0.24	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.15	2.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	7.90	3.11	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.93	3.84	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	7.79	3.48	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.45	3.34	0.22	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.19	3.19	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.24	2.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	12.58	23.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	10.10	3.67	0.00	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.05	2.92	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	13.49	1.28	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	8.17	5.34	0.31	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	3.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	2.80	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	7.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	11.21	4.76	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.02	2.27	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	14.20	2.48	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	31.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.83	0.49	0.00	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	12.40	1.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.91	0.94	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.26	2.65	0.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.45	3.09	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	11.92	1.53	0.92	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	11.09	3.96	0.00	0.32	0.00
Adipocyte - breast, donor2	11327-117E4	11.07	2.25	0.16	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	11.20	5.98	0.13	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	12.71	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	9.04	1.67	0.33	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	3.83	2.55	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	10.84	2.26	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.17	0.70	0.35	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	13.69	0.98	0.98	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	11.58	0.51	0.51	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	12.27	3.07	0.56	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	17.05	1.18	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	15.20	1.61	0.08	0.08	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	12.26	0.65	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	2.67	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	13.35	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.15	2.50	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	13.56	1.51	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	7.20	2.29	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	11.27	0.30	0.30	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	11.05	2.87	0.22	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	1.08	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	12.05	0.72	0.90	0.90	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	6.99	1.64	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	8.01	1.83	0.34	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	9.31	1.47	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	4.49	4.04	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	2.17	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.37	3.59	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	5.06	2.53	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.98	2.64	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.50	2.60	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	3.88	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	1.78	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.91	2.64	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	4.35	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	2.51	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	8.90	3.46	0.00	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.69	2.26	0.00	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.57	2.14	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.50	2.46	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	4.81	2.14	0.27	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	1.95	0.00	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.96	2.32	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	6.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.89	2.40	0.34	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	3.88	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.11	4.17	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	4.56	2.85	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	6.84	2.57	0.00	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.52	2.84	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	5.63	1.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.40	2.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	2.85	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	2.34	4.09	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.32	3.01	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	2.38	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.10	2.03	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.70	2.29	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	7.62	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	2.59	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.99	1.06	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.67	2.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	3.78	4.72	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	6.61	1.86	0.51	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.15	3.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	0.60	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.98	3.68	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.92	4.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	9.50	2.06	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	8.87	3.37	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	1.43	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	8.20	2.22	0.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	2.77	1.11	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.53	2.38	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	5.82	1.82	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	13.39	2.21	0.37	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	10.10	1.88	0.86	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.60	0.63	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	24.05	2.09	1.39	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	27.83	3.56	1.46	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	30.28	1.79	1.19	1.64	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.17	8.95	0.92	0.57	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	49.24	10.90	1.88	0.88	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	47.79	8.08	1.25	1.48	0.68
Basophils, donor1	12241-129G9	12.82	8.11	0.26	0.26	0.00
Basophils, donor2	12242-129H1	36.80	20.57	0.72	0.36	0.00
Basophils, donor3	12243-129H2	15.73	4.12	0.44	0.29	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	4.53	0.22	0.43	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.97	3.77	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.27	2.29	0.00	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	11.74	1.61	0.46	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	10.98	1.08	0.36	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	49.36	21.44	1.85	0.62	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	55.90	12.81	2.10	1.16	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	43.49	15.67	0.96	0.64	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	41.37	10.34	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	16.91	4.51	0.56	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	13.18	12.62	0.74	0.74	0.56
CD14+ Monocytes, donor3	11381-118B4	17.78	14.27	0.00	1.10	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	25.19	1.42	0.57	0.28	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.57	3.79	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	24.00	1.97	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	12.58	1.59	0.29	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	12.67	2.11	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	17.53	4.50	0.24	0.47	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.70	1.84	0.00	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.21	1.93	0.28	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.45	0.50	0.25	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.46	1.37	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.48	1.96	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	10.23	1.09	0.00	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.96	1.40	1.17	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.14	3.70	1.06	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	2.22	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.67	1.64	0.00	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.78	1.40	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.28	1.87	0.21	0.21	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.92	1.60	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.11	3.85	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	6.98	1.31	0.00	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	10.49	0.81	0.27	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	7.68	2.09	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	14.31	2.52	0.42	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.23	1.29	0.37	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.64	0.70	1.06	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.95	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	6.80	2.96	0.00	0.35	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	6.32	4.09	1.12	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	8.84	4.53	0.43	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.50	0.82	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.26	2.55	0.46	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	7.42	1.16	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	22.45	6.97	0.65	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	20.56	8.55	0.46	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	19.06	5.20	0.00	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	23.98	4.36	0.31	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	19.56	4.37	0.17	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	22.07	6.69	0.89	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	22.46	4.85	0.26	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	23.49	3.73	0.22	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	21.48	4.84	0.21	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	6.10	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	38.64	3.39	2.03	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	33.14	4.14	2.07	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	37.31	5.86	1.07	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	36.99	5.90	0.54	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.18	2.11	0.00	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	34.51	1.57	2.35	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	43.50	5.27	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	22.19	25.48	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	22.49	15.23	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	19.69	17.16	3.03	0.50	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	72.73	9.70	3.23	2.42	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	47.54	4.79	3.99	1.20	2.00
CD34+ Progenitors, donor1	11545-120B6	22.09	31.13	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	29.78	35.39	0.00	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	41.33	10.15	0.00	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	40.59	15.11	1.58	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	48.20	37.85	8.57	10.35	1.07
CD4+ T Cells, donor2	11306-117C1	33.07	39.80	4.90	6.12	1.22
CD4+ T Cells, donor3	11382-118B5	34.46	22.26	1.22	3.96	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	35.99	2.81	1.02	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	30.55	0.67	0.00	0.67	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	32.48	2.30	0.57	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	37.93	12.33	2.84	4.74	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	32.31	8.43	0.70	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	13.18	6.59	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	23.12	4.34	0.14	0.29	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.86	2.71	0.17	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	24.50	2.58	0.32	0.32	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	39.45	14.35	1.34	2.69	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	37.04	6.64	0.35	1.75	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	31.68	12.32	1.32	0.88	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	39.63	2.53	0.84	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	30.54	1.87	0.00	0.62	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	23.72	3.68	0.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	35.62	7.61	3.81	5.98	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	39.12	5.90	2.68	2.14	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	3.59	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	39.50	3.34	0.56	0.74	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.09	1.73	1.08	0.87	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	34.25	3.15	0.42	0.63	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	31.85	8.60	0.51	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	28.16	11.70	1.30	2.60	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	32.69	10.02	1.31	3.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	47.01	2.47	1.98	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	47.08	1.85	0.00	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	0.00	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	42.09	5.82	1.11	1.66	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	49.57	3.68	1.47	2.45	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	4.62	6.16	7.70	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	44.76	2.86	1.07	1.43	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	39.61	29.14	1.96	4.26	0.65
CD8+ T Cells, donor2	11307-117C2	34.92	37.92	1.50	3.75	0.38
CD8+ T Cells, donor3	11383-118B6	40.15	40.90	3.28	6.56	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	18.12	5.05	0.46	0.69	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.30	4.55	0.24	0.96	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.49	5.47	0.27	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.72	9.31	0.30	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.00	6.48	0.72	0.72	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.83	5.91	0.91	1.36	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.03	9.56	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	21.58	8.42	0.26	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.17	7.50	0.23	0.94	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	23.85	6.34	0.91	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.73	5.81	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.38	5.06	0.27	1.60	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.45	11.38	0.44	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	13.66	7.74	0.46	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.17	5.22	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.13	8.28	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.26	6.04	0.29	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	15.32	5.89	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.94	10.77	1.27	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.61	7.07	0.31	0.62	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.29	10.58	0.96	0.96	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	21.04	6.88	0.76	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.28	7.49	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	7.56	8.32	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.88	13.65	1.61	1.61	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	19.58	18.88	2.80	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	18.03	19.03	1.00	3.01	1.00
Cardiac Myocyte, donor1	11525-119I4	1.83	1.83	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	7.91	3.95	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	11.58	1.89	0.21	0.32	0.21
Chondrocyte - de diff, donor1	11261-116G1	28.77	4.51	0.69	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	9.95	0.71	0.00	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	11.26	1.82	0.11	0.00	0.11
Chondrocyte - re diff, donor2	11339-117F7	32.23	6.27	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	8.49	1.21	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	17.67	3.21	0.92	0.46	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	11.12	2.35	0.00	0.64	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	12.92	3.54	0.27	0.80	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.96	3.30	2.48	1.38	0.46
Corneal Epithelial Cells, donor1	11526-119I5	4.61	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	3.41	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.20	0.77	0.26	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.67	1.65	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	15.46	0.63	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.06	1.73	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	35.19	12.30	0.00	1.37	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	31.34	16.32	0.65	2.61	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.01	18.39	1.94	1.45	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	12.84	2.84	0.17	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	11.74	1.17	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	9.05	1.70	0.57	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	3.93	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	6.98	2.04	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	11.76	1.65	0.24	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	13.67	2.28	0.53	0.53	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	11.97	1.99	0.22	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.95	2.13	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.40	1.41	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	4.46	0.89	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	3.64	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.53	0.14	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	24.41	6.00	0.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	4.72	0.52	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.19	5.72	0.50	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.64	2.17	0.43	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	23.94	2.81	0.85	0.49	0.24
Endothelial Cells - Vein, donor1	11267-116G7	9.10	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	13.50	1.73	0.47	0.16	0.16
Eosinophils, donor1	12244-129H3	60.99	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	31.35	21.45	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	10.70	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	0.24	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	10.67	3.69	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.79	2.96	0.22	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.33	2.17	0.33	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.52	4.37	0.73	0.49	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.33	11.05	0.55	1.36	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.86	2.85	0.21	0.42	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	11.33	4.48	0.26	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.94	4.98	0.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	11.34	2.72	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	5.31	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.10	1.73	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	25.76	4.24	0.00	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	22.46	4.70	0.76	0.25	0.25
Fibroblast - Cardiac, donor6	11460-119B2	20.16	3.94	0.30	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.27	2.95	0.13	0.40	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	9.49	2.59	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	1.46	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.14	2.77	0.92	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	11.36	4.24	0.34	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	16.20	4.70	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	17.92	3.30	0.47	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	15.96	3.38	0.12	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	32.33	3.39	0.57	0.45	0.11
Fibroblast - Dermal, donor5	11454-119A5	35.07	2.44	1.40	0.87	0.00
Fibroblast - Dermal, donor6	11458-119A9	34.43	6.01	1.79	0.49	0.65
Fibroblast - Gingival, donor1	11237-116D4	14.16	2.08	0.42	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	19.39	3.41	0.26	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	19.50	1.45	1.05	0.53	0.26
Fibroblast - Gingival, donor3	11394-118C8	15.66	1.74	0.29	0.29	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	20.78	3.12	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	7.75	1.41	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	21.05	5.14	0.62	0.62	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	18.80	5.68	0.68	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.06	2.12	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	18.43	5.12	0.88	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	18.54	5.32	0.68	0.95	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	30.93	10.97	1.21	0.66	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	11.74	3.23	0.44	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	8.16	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	23.87	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	16.67	1.48	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	8.33	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	0.56	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	18.27	3.65	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	27.74	2.13	0.78	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	31.09	2.28	0.46	0.30	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	32.43	3.37	1.53	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.26	2.67	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	13.23	3.78	0.27	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	11.02	1.86	0.12	0.35	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	20.56	4.42	0.44	0.55	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	14.22	3.66	0.61	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.26	0.40	0.79	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.86	5.95	0.40	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.08	1.78	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	16.95	4.14	0.20	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.95	4.81	0.90	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	15.33	4.10	0.43	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.93	2.53	0.51	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	12.47	1.15	0.66	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.06	6.62	0.40	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	17.08	4.22	0.50	0.00	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	14.51	5.74	0.91	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.51	2.73	0.33	0.50	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.53	4.79	0.17	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	15.44	4.27	0.33	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.05	4.05	0.21	0.00	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	19.90	1.35	0.34	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	1.57	0.16	0.00	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	110.80	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	6.10	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.56	3.29	0.17	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.40	5.20	0.78	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	22.74	3.32	0.00	1.02	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	42.87	17.61	3.83	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	35.73	22.97	7.66	4.47	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	53.34	12.55	13.41	3.14	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.92	3.58	1.65	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	25.57	6.39	4.11	0.68	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	43.79	9.51	5.55	2.97	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	32.78	5.29	2.11	1.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	27.07	3.91	2.28	2.61	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	56.16	10.61	7.08	2.65	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	25.16	7.63	4.80	0.71	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	24.87	4.56	4.31	0.74	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	27.13	6.98	3.22	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	23.29	3.35	2.35	0.99	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	23.67	4.01	4.15	1.52	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	23.79	6.51	3.25	1.22	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	20.08	2.51	2.74	1.14	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	16.57	3.36	2.37	0.87	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	17.70	2.40	2.40	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	15.07	1.48	2.95	1.18	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	20.66	2.23	2.38	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	17.20	2.23	2.01	0.22	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	18.95	2.62	2.02	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	24.09	3.22	2.04	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	28.82	6.03	3.01	1.86	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.33	2.71	0.62	0.73	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.86	1.54	2.05	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	19.92	2.43	1.88	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.29	4.66	1.41	0.83	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.68	6.74	3.06	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.95	2.06	0.83	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	18.45	2.88	1.96	0.46	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.68	3.17	0.33	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.55	1.10	1.98	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	18.57	1.97	1.72	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	19.29	5.35	2.27	1.30	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	15.39	1.60	1.92	0.96	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	15.73	1.23	1.14	0.66	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.35	1.27	0.16	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	13.99	3.04	0.91	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	16.73	1.67	0.94	0.63	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.78	1.98	0.44	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.67	0.84	1.40	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	16.02	2.59	0.56	0.37	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.51	3.48	0.80	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	19.28	4.13	0.31	0.61	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.17	1.68	0.26	0.91	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.96	1.63	0.54	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	12.54	1.47	0.00	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.60	1.97	1.10	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	14.88	4.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	10.95	1.32	0.26	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.30	2.22	0.00	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	18.55	4.07	0.00	0.51	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	43.79	17.32	6.37	1.99	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	26.35	8.01	4.78	1.39	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	38.46	12.27	6.75	2.05	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	40.06	13.14	5.95	1.88	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	36.73	10.17	4.52	1.41	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	45.66	14.30	5.53	1.38	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	12.37	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	40.61	14.70	3.48	2.71	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	48.13	9.63	4.81	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	1.74	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	35.48	8.79	3.25	1.95	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	32.53	6.59	3.29	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	6.66	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	31.60	6.15	2.52	0.84	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	28.44	5.23	3.27	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	26.00	4.19	3.36	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	35.62	7.63	3.18	0.95	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	30.23	5.09	2.04	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	31.32	6.26	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	24.63	4.58	3.44	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	20.42	2.07	2.66	0.30	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	11.86	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.14	11.18	2.49	1.66	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	30.61	8.51	1.84	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	10.54	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.06	3.46	2.31	0.38	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.49	3.59	2.61	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	32.10	3.34	0.00	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	23.89	3.08	1.93	0.77	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	39.03	20.54	2.40	1.71	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	2.48	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	27.84	1.42	2.83	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	16.29	1.21	2.41	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.57	3.56	3.56	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	22.73	3.19	3.59	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	24.67	2.47	0.99	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	8.26	3.54	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	26.84	0.58	1.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.46	1.32	3.51	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	13.56	2.54	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.02	5.97	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.01	6.79	0.97	2.43	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	5.71	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.57	0.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	7.61	3.81	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.03	3.34	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	32.96	5.45	0.46	0.58	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	32.24	6.25	1.69	1.01	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	29.12	6.37	1.14	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	31.59	6.01	1.31	0.77	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	32.24	6.23	0.64	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	30.57	6.24	0.22	1.29	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	28.15	7.72	0.87	1.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	29.68	6.18	1.03	0.86	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	29.47	5.77	1.28	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.35	3.92	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.49	2.16	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	2.64	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.23	0.71	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.91	5.59	0.52	0.35	0.35
Hepatocyte, donor1	11523-119I2	15.74	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	14.01	2.15	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	16.57	1.23	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.04	5.22	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.05	6.99	3.32	1.05	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	10.02	1.65	0.69	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	9.55	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	8.31	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	7.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	7.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	24.36	3.25	1.62	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	23.34	5.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	23.82	1.32	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	4.43	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	28.97	6.93	0.00	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	6.19	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	30.36	6.46	0.00	1.29	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	24.15	3.22	1.61	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	28.52	3.26	1.63	2.44	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.57	5.04	1.26	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	29.74	4.82	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	23.13	3.78	0.47	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	22.67	3.63	0.91	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	14.74	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	25.83	2.15	4.30	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	1.27	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	26.14	0.64	1.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	38.28	7.29	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	22.85	3.57	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	23.77	2.78	0.62	1.23	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	7.02	3.51	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.03	1.39	1.39	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	0.00	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	1.74	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	4.50	2.25	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	3.48	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	21.34	2.13	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	0.00	2.77	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	15.65	1.84	0.92	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	14.80	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.73	0.98	0.16	0.49	0.08
Keratinocyte - epidermal, donor2	11349-117G8	7.03	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	25.75	2.37	0.95	0.47	0.28
Keratinocyte - oral, donor1	11251-116E9	16.91	2.27	0.11	0.68	0.23
Keratocytes, donor1	11527-119I6	18.57	2.06	2.06	1.38	0.00
Keratocytes, donor2	11607-120I5	10.55	4.69	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	14.23	2.17	1.19	0.99	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	12.57	1.38	0.58	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	9.38	2.32	0.61	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.49	1.90	0.24	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	0.56	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	11.02	2.83	0.00	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	5.99	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.22	1.51	0.00	0.11	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.39	1.23	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.31	1.26	0.76	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	6.47	1.83	0.00	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	1.98	0.79	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.76	1.36	1.36	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.96	0.74	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.06	0.35	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.20	1.19	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.22	1.65	0.27	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	10.47	1.54	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.68	1.25	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.59	2.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.23	1.32	1.65	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	1.46	1.17	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.23	1.74	0.00	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	4.36	0.48	1.45	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.54	2.42	0.54	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.78	2.72	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	7.26	0.52	1.56	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.54	2.09	1.88	1.26	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.97	2.41	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	0.69	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	8.28	1.32	0.94	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	4.88	0.85	0.00	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	8.72	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	2.32	0.66	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.96	0.87	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.55	2.22	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.15	1.48	1.24	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	5.50	1.24	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.40	0.64	0.64	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.96	2.74	0.61	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	9.10	1.82	0.14	0.42	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.09	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.82	1.94	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	4.05	1.09	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	8.95	1.07	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	2.29	0.00	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.35	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	12.99	1.24	0.12	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.61	1.28	0.51	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.35	2.09	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	9.06	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	21.48	6.14	2.30	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	18.56	0.74	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.23	5.92	2.54	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.85	6.33	1.41	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	1.87	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.88	4.64	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	1.19	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.81	3.17	0.68	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	17.16	7.85	0.29	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	21.16	4.95	0.45	0.00	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.32	3.79	0.95	0.68	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	19.51	3.59	1.03	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	16.94	5.65	1.41	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	19.99	2.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	4.08	2.55	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	20.28	6.94	1.60	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.67	6.61	0.94	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	7.36	1.23	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.83	3.26	2.45	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	16.87	5.41	0.62	1.46	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	16.82	4.76	1.12	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	36.06	4.12	2.06	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.87	3.77	0.87	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	18.83	4.78	0.00	0.90	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	19.92	2.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	21.56	7.07	0.71	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.18	5.16	1.84	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	26.48	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.20	3.84	0.00	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	12.45	6.23	0.57	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	16.41	4.10	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	18.53	7.23	1.36	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	18.67	2.87	2.15	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.18	2.99	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	20.07	2.60	1.11	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	13.35	2.58	1.72	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	3.43	1.71	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	17.66	5.00	0.33	2.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	20.51	3.62	2.41	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	2.13	0.00	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.72	2.75	1.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	19.32	4.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.79	1.35	1.35	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	15.56	2.22	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	16.28	3.49	2.33	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	2.12	2.12	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	21.21	3.20	0.80	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	19.63	6.54	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.10	2.30	0.77	2.30	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	20.22	6.91	0.99	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	12.23	3.76	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.12	4.02	1.01	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.48	6.31	1.35	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	6.88	0.00	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	21.38	5.79	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	17.60	2.74	1.56	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.77	6.60	0.00	3.30	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.28	6.23	2.08	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	23.19	5.25	2.19	0.88	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.33	6.71	1.68	1.68	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	23.85	3.09	0.88	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.69	5.40	1.54	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	15.19	4.56	1.01	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	20.67	5.77	2.40	1.44	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	18.29	3.58	0.40	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	13.37	6.68	1.22	2.43	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	16.60	6.92	0.69	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.48	6.84	1.90	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	22.21	8.26	3.10	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.93	6.65	3.63	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.04	6.02	3.80	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	24.52	7.46	1.07	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.58	4.02	2.87	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	26.74	3.60	3.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	25.46	3.54	1.41	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	22.13	4.54	1.70	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	23.30	5.82	0.83	1.25	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	24.27	6.26	1.57	1.57	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	20.04	4.59	2.92	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.56	3.25	0.46	0.00	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	16.06	4.01	6.02	2.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	17.11	6.42	4.81	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.67	4.45	2.02	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	4.59	2.75	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	11.56	8.00	4.45	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.78	6.27	1.14	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.80	3.07	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	3.83	2.19	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.49	2.23	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.78	5.20	1.30	0.52	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	25.20	5.97	1.99	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	10.39	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	13.45	2.73	0.46	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	12.85	0.92	0.18	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	15.73	1.31	0.26	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.40	7.43	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	15.21	3.64	0.48	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	19.32	5.70	0.14	0.69	0.42
Mammary Epithelial Cell, donor1	11273-116H4	23.12	8.77	1.20	0.90	0.20
Mammary Epithelial Cell, donor2	11350-117G9	25.48	7.24	0.29	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	11.97	0.75	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	65.08	12.20	0.68	2.03	0.00
Mast cell, donor1	11563-120D6	22.93	4.54	0.00	0.22	0.11
Mast cell, donor2	11565-120D8	21.99	12.18	1.19	0.59	0.30
Mast cell, donor3	11566-120D9	32.87	11.93	1.58	0.68	0.45
Mast cell, donor4	11567-120E1	25.35	17.73	1.06	0.71	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	25.84	2.22	0.11	0.33	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	17.51	4.09	1.75	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	22.49	1.49	0.00	0.00	0.23
Mast cell, expanded, donor8	11941-126A6	25.11	2.01	0.33	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	13.13	2.49	0.40	0.50	0.10
Melanocyte - dark, donor2	11582-120F7	7.61	1.38	1.04	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	35.42	3.84	0.65	0.51	0.43
Melanocyte - light, donor1	11274-116H5	8.93	2.12	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.24	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	1.73	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	23.64	3.44	0.31	0.42	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	24.47	1.34	0.54	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	19.02	3.48	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	23.57	3.72	0.62	0.99	0.25
Meningeal Cells, donor2	11573-120E7	21.57	1.32	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	29.42	6.60	0.98	0.98	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	14.26	3.42	1.14	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.26	2.92	0.10	0.00	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	17.22	2.87	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	11.86	1.91	0.42	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.08	3.02	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.43	1.76	0.22	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.05	1.43	0.61	0.61	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.80	1.80	0.14	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.20	0.74	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	10.26	3.68	0.53	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	1.48	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.68	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.75	1.06	1.06	1.77	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	10.32	2.50	0.63	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	5.08	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.52	4.51	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	7.51	3.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	8.31	2.82	0.14	0.07	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.49	2.22	0.00	0.99	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.89	1.18	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	16.12	1.55	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.94	2.07	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	17.02	1.50	0.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	12.10	1.40	0.47	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	15.44	1.63	0.00	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.09	1.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	1.77	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	11.40	3.04	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.06	2.12	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.64	2.09	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.53	2.26	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	9.03	1.43	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.53	1.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.83	3.37	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.93	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.44	3.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.67	2.67	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.04	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	2.03	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	1.09	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.29	2.65	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	2.40	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.20	0.80	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	8.23	1.37	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	0.00	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.57	1.31	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.41	1.98	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.21	1.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	9.82	2.81	0.00	0.84	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.48	2.91	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.66	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.95	1.81	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.85	2.09	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	1.85	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	13.66	2.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.43	1.24	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.88	2.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	14.16	2.57	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.34	2.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.47	2.10	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.17	0.85	0.14	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.19	2.23	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.05	4.20	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.34	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	9.94	2.84	0.57	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.32	2.95	0.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.00	0.59	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.82	2.88	0.58	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.91	0.89	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.11	1.64	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	2.10	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.61	1.98	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	14.90	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.14	1.50	0.00	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	12.25	0.80	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.99	1.47	0.34	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	15.47	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.82	1.10	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	1.56	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.29	1.60	1.60	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.85	1.26	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	2.72	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.00	0.00	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.81	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	17.13	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	13.05	6.52	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	19.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	62.75	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	15.08	7.54	0.22	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	10.97	2.61	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	0.67	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.36	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	23.01	4.94	0.19	0.38	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	1.60	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	9.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	21.85	3.72	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.32	1.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.98	1.68	0.00	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	44.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.91	1.49	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.12	2.44	0.54	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.96	3.17	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.96	1.31	0.00	0.33	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.67	2.92	0.36	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.32	0.53	0.00	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	0.60	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	18.71	3.28	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.32	0.65	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	16.40	3.70	0.00	0.88	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.03	0.92	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.71	0.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.14	8.28	0.00	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	7.59	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.26	2.45	0.67	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.28	1.27	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	11.87	0.71	0.47	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.31	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	36.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	15.99	2.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	2.25	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	2.38	0.40	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	2.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.78	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.34	0.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	0.00	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.76	2.26	0.45	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	1.76	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	8.64	1.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	16.37	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	14.82	0.91	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.05	2.21	0.44	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	10.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	14.48	1.26	0.00	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.50	0.91	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	12.47	5.67	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	15.28	4.72	0.25	0.37	0.12
Myoblast, donor2	11322-117D8	16.11	3.07	0.58	0.77	0.19
Myoblast, donor3	11398-118D3	20.35	3.87	0.17	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	23.06	2.92	0.58	0.29	0.29
Natural Killer Cells, donor1	11230-116C6	45.82	24.29	1.85	2.46	0.62
Natural Killer Cells, donor2	11311-117C6	31.06	37.39	1.51	2.71	0.00
Natural Killer Cells, donor3	11387-118C1	33.31	32.03	3.87	2.76	0.55
Neural stem cells, donor1	11275-116H6	34.84	6.90	1.09	1.45	0.36
Neural stem cells, donor2	11352-117H2	48.14	7.70	0.00	1.93	0.00
Neurons, donor1	11494-119E9	35.27	11.38	2.28	1.14	1.14
Neurons, donor2	11574-120E8	21.80	2.64	0.66	0.44	1.10
Neurons, donor3	11655-122E8	27.95	2.47	4.11	0.82	0.82
Neutrophils, donor1	11233-116C9	33.41	13.92	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	14.49	5.80	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	37.26	8.55	1.22	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	11.64	1.42	0.12	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	5.21	0.65	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	9.63	1.20	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	12.66	3.58	0.14	0.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	10.42	3.33	0.00	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	10.10	2.27	0.00	0.23	0.00
Olfactory epithelial cells, donor4	11936-126A1	11.98	1.07	0.39	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	13.24	1.20	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	6.17	1.91	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.86	1.56	0.78	0.20	0.20
Osteoblast, donor2	11354-117H4	18.96	4.92	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	13.51	2.84	0.36	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	16.85	3.79	0.08	0.34	0.00
Pericytes, donor1	11491-119E6	3.67	0.22	0.11	0.00	0.00
Pericytes, donor2	11571-120E5	6.56	1.36	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	6.92	0.41	0.61	0.00	0.00
Perineurial Cells, donor1	11499-119F5	13.90	1.24	0.23	0.23	0.34
Perineurial Cells, donor2	11579-120F4	15.73	3.59	0.37	0.18	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	25.50	7.97	0.96	0.64	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	21.30	12.24	1.22	1.22	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	26.14	10.48	0.65	1.04	0.26
Placental Epithelial Cells, donor1	11278-116H9	11.72	2.15	1.43	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	7.76	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.10	1.57	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.06	1.58	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	11.82	3.38	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.57	2.74	0.39	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	10.81	1.35	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	14.49	3.41	0.21	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	18.33	1.31	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	12.61	3.15	0.29	0.14	0.29
Preadipocyte - perirenal, donor1	11469-119C2	6.89	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.14	4.30	0.31	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	26.56	7.26	0.89	0.35	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	21.80	6.47	0.00	0.17	0.17
Preadipocyte - visceral, donor1	11280-116I2	24.78	6.05	0.56	0.47	0.09
Preadipocyte - visceral, donor2	11357-117H7	11.50	6.90	0.46	1.38	0.46
Preadipocyte - visceral, donor3	11429-118G7	22.47	3.55	0.21	0.31	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	48.88	14.18	4.53	2.26	0.91
Prostate Epithelial Cells, donor2	11331-117E8	10.70	2.17	0.27	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	9.06	1.10	0.73	1.22	0.24
Prostate Stromal Cells, donor1	11254-116F3	17.65	5.81	0.34	0.80	0.57
Prostate Stromal Cells, donor2	11332-117E9	15.42	3.77	0.36	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	9.70	2.19	0.10	0.21	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	5.11	0.73	0.36	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.64	1.80	0.97	0.35	0.21
Renal Epithelial Cells, donor1	11517-119H5	6.59	1.01	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	1.42	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	14.82	2.33	0.95	0.21	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.13	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.76	2.43	0.27	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	9.77	3.33	0.67	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.22	0.44	0.66	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	0.55	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.30	1.61	0.54	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.86	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	7.52	1.54	0.39	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.26	1.81	0.78	1.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.23	3.13	0.28	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.03	1.51	0.75	1.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.44	1.20	1.07	0.27	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	25.02	2.68	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.12	11.01	1.10	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.84	5.80	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	32.90	7.15	1.04	0.78	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	31.98	5.46	0.70	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	41.27	8.59	1.23	0.89	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	36.72	8.56	2.23	0.99	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	32.17	5.59	0.82	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	40.45	6.47	2.54	1.62	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	22.86	5.07	0.82	0.82	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	30.25	6.05	0.91	1.06	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	35.84	6.63	1.79	1.25	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	29.70	6.03	1.00	0.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	31.66	5.15	0.86	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	42.04	7.08	1.11	1.33	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	24.85	4.21	1.53	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	30.93	5.12	1.40	0.75	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	39.46	11.46	2.07	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	29.46	4.25	0.53	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	34.36	5.45	1.07	0.88	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	31.51	7.64	0.95	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	29.58	4.91	0.53	0.53	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	23.27	7.57	0.84	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	31.62	6.32	0.85	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	25.89	3.28	0.55	0.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	29.80	5.64	0.61	1.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	38.28	8.19	0.54	0.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	29.25	8.02	0.94	0.94	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	32.74	6.55	0.99	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	38.82	7.72	0.70	1.87	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	32.76	7.26	0.62	0.83	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	33.18	8.18	1.33	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	43.24	5.64	1.46	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	34.32	7.13	1.21	0.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	35.59	5.79	1.36	1.19	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	44.15	6.75	1.54	1.35	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	26.31	3.27	1.55	1.03	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	29.22	3.57	0.55	0.82	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	35.79	5.75	1.48	0.82	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.13	2.56	1.53	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	31.96	2.96	1.78	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	34.65	4.53	1.87	0.80	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	22.81	4.01	0.69	0.41	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	33.81	5.00	1.19	0.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	37.89	6.05	1.21	1.41	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	25.80	5.09	0.85	0.47	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	24.11	3.14	0.35	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	26.29	4.84	1.21	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	30.23	5.63	0.86	0.37	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	42.06	11.50	1.60	1.60	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	28.60	8.52	1.22	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	29.54	3.62	1.81	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.92	4.98	0.45	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	24.26	4.79	0.90	2.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	25.62	6.02	0.47	0.47	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	26.89	4.48	0.43	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.85	3.00	2.40	2.40	1.20
Schwann Cells, donor1	11498-119F4	8.09	0.56	0.19	0.00	0.38
Schwann Cells, donor2	11578-120F3	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	11.17	1.75	0.44	0.00	0.00
Sebocyte, donor1	11220-116B5	14.24	3.83	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	11.03	5.06	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	10.10	1.44	0.00	0.21	0.41
Sertoli Cells, donor1	11255-116F4	16.57	6.63	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	8.47	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.84	1.32	0.44	0.26	0.09
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	18.39	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.02	3.93	0.47	0.94	0.47
Skeletal Muscle Cells, donor5	11455-119A6	26.46	3.12	0.45	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	31.55	6.77	1.08	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	13.86	3.28	0.38	0.50	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.69	2.71	0.00	0.71	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	31.25	4.96	0.89	1.09	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.40	1.60	0.34	0.34	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	16.65	1.45	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.77	2.06	0.14	0.28	0.00
Skin - palm, donor1	10286-104F7	48.35	2.69	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.80	1.59	0.29	0.29	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	41.71	8.18	0.82	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.39	1.82	0.13	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	9.59	3.34	0.42	0.42	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	12.94	1.83	0.84	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	38.48	7.82	1.48	0.21	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	11.32	0.52	0.82	0.67	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.41	3.39	0.62	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	7.34	5.11	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.23	1.18	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.19	1.99	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.81	2.36	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	15.45	0.77	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.72	1.33	0.27	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.40	7.76	0.22	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.31	5.51	0.38	0.77	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.70	1.95	0.65	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	19.20	3.25	1.48	0.00	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.10	1.42	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.55	0.00	0.00	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	3.35	0.61	0.30	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.32	1.26	0.00	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.72	1.91	0.95	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.01	1.03	0.74	0.59	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.90	3.01	1.08	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.32	2.31	0.63	0.10	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.89	2.94	0.46	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	4.31	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	3.29	0.00	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.17	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.76	2.04	0.08	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.37	4.53	0.20	0.10	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	14.34	2.73	0.68	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.83	4.23	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	36.56	7.42	2.12	2.12	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	18.38	3.33	0.53	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	13.02	3.13	0.25	0.38	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	12.68	3.04	0.00	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	14.32	2.41	0.30	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	7.50	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	6.46	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.30	1.86	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	4.54	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	9.09	3.13	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.65	0.88	0.00	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	25.49	4.00	0.92	0.75	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	10.28	0.93	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.91	0.72	0.00	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	8.92	2.80	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	11.28	0.56	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.83	4.05	0.42	0.56	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8.04	1.51	0.17	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.33	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.83	0.98	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.48	5.30	0.44	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	14.04	2.63	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.16	0.78	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.52	5.02	0.26	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.18	5.95	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	7.19	1.80	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.21	4.26	0.85	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.54	5.12	0.39	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	2.29	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	11.58	1.20	0.00	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	2.93	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	12.83	1.83	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	9.59	2.52	0.34	0.50	0.17
Synoviocyte, donor2	11368-117I9	13.07	3.52	0.17	0.17	0.17
Synoviocyte, donor3	11440-118H9	10.72	2.23	0.00	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	1.79	0.36	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.35	1.62	0.23	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	12.19	2.65	0.86	0.29	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	8.50	1.55	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	1.72	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	18.70	1.11	0.37	0.25	0.12
Urethra, donor2	10319-105A4	12.59	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	8.50	1.86	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	4.81	0.80	0.40	0.80	0.00
Urothelial Cells, donor3	11681-122H7	2.98	1.15	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	15.16	0.89	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.91	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	24.30	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	15.74	0.00	0.68	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.97	1.72	1.03	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	18.01	0.58	1.16	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	23.95	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	18.36	2.75	0.92	0.92	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	1.83	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	48.60	12.71	1.36	0.99	0.49
Wilms' tumor cell line:HFWT	10597-108E3	14.08	0.00	0.00	1.76	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	40.22	9.78	1.40	0.56	0.56
achilles tendon, donor2	10292-104G4	16.53	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	48.44	11.47	1.02	0.51	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	69.19	13.23	1.39	0.70	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	62.20	11.28	3.32	0.59	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	90.89	7.89	1.63	1.09	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	60.15	10.68	0.84	0.84	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	41.87	11.84	0.63	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	35.12	8.44	1.09	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	66.98	17.18	0.88	1.76	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	51.86	8.98	0.00	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	72.22	12.04	0.39	0.39	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	29.62	5.52	0.55	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	19.50	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	35.09	8.60	0.23	0.70	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	61.62	8.80	1.55	1.04	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	40.91	7.01	1.17	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	33.00	7.90	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	44.42	6.17	0.82	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	29.77	1.53	0.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	66.99	11.09	1.28	2.13	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	56.72	6.98	1.52	1.21	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	69.56	9.63	1.68	1.44	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	47.22	6.01	1.78	2.00	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	48.70	7.34	2.33	2.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	65.04	1.86	1.86	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	59.51	7.91	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	44.49	6.98	0.44	1.74	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	71.23	7.50	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	52.75	3.06	1.18	0.94	0.24
adipose tissue, adult, pool1	10010-101C1	14.27	0.62	0.31	0.00	0.16
adipose, donor1	10184-103D4	53.95	12.31	2.35	0.59	0.59
adipose, donor2	10185-103D5	14.19	2.43	4.46	0.81	0.00
adipose, donor3	10186-103D6	23.69	4.63	2.45	1.36	0.54
adipose, donor4	10187-103D7	39.00	8.67	2.60	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	63.60	1.89	0.79	0.32	0.63
adrenal gland, adult, pool1	10081-102A9	25.46	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	32.42	12.41	1.33	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	51.09	4.64	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	14.84	2.55	0.23	1.16	0.23
amniotic membrane cells, donor2	12236-129G4	12.85	0.68	0.34	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	8.84	4.42	0.88	0.59	0.00
amygdala - adult, donor10196	10167-103B5	27.27	2.37	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	20.07	2.23	1.22	0.00	0.61
amygdala, newborn, donor10223	10360-105E9	14.20	5.49	5.16	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	15.15	2.29	0.64	0.25	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	48.76	7.06	1.99	2.43	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	51.11	15.70	2.34	0.67	0.67
aorta, adult, pool1	10052-101G7	16.87	1.37	0.78	0.00	0.20
appendix, adult	10189-103D9	28.33	3.88	1.16	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	29.92	12.73	0.34	1.03	0.34
artery, adult	10190-103E1	23.10	1.36	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	15.50	1.74	0.14	0.14	0.00
b cell line:RPMI1788	10427-106D4	26.32	7.73	0.59	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.38	2.50	0.00	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	19.05	5.46	1.09	0.60	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	20.42	1.67	1.51	1.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.88	8.95	1.12	0.56	0.00
bladder, adult, pool1	10011-101C2	13.15	1.09	0.98	0.22	0.65
blood, adult, pool1	10053-101G8	19.93	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.13	2.57	0.86	0.86	0.86
bone marrow, adult	10192-103E3	10.12	2.02	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	18.45	3.08	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	17.71	2.00	0.33	0.45	0.56
brain, fetal, pool1	10085-102B4	13.36	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	42.62	7.60	0.66	0.99	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	42.69	2.87	1.25	0.50	0.50
breast, adult, donor1	10080-102A8	16.42	0.63	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	49.42	3.05	0.64	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.17	0.93	1.55	0.62	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	19.11	4.60	1.38	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.47	4.12	0.48	1.69	0.48
carcinoid cell line:NCI-H1770	10703-109H1	44.20	3.29	4.70	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	20.89	1.86	1.31	1.09	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	23.77	1.90	0.63	0.63	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	49.51	11.45	1.33	1.06	0.53
caudate nucleus - adult, donor10196	10177-103C6	18.42	1.15	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	19.91	2.01	1.00	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	25.98	3.06	1.53	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	16.48	5.49	5.86	1.46	0.73
cerebellum - adult, donor10196	10173-103C2	72.83	5.83	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	33.31	3.63	6.83	2.78	1.07
cerebellum, adult, pool1	10083-102B2	28.63	3.79	2.76	0.69	0.69
cerebellum, newborn, donor10223	10357-105E6	24.91	5.81	8.30	8.30	0.83
cerebral meninges, adult	10188-103D8	17.90	3.78	2.02	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	15.35	2.92	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	37.24	3.31	1.44	0.86	0.43
cervical cancer cell line:ME-180	10553-107I4	24.36	5.47	1.33	1.49	0.50
cervix, adult, pool1	10013-101C4	16.69	1.47	2.20	0.31	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	21.74	4.18	0.42	0.42	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	35.29	4.23	3.23	1.37	0.62
choriocarcinoma cell line:SCH	10785-110H2	44.85	3.70	1.60	0.74	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	29.65	1.90	3.08	2.61	1.19
chorionic membrane cells, donor1	12238-129G6	10.83	3.13	0.57	0.28	1.42
chorionic membrane cells, donor2	12239-129G7	21.28	3.08	0.50	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	17.03	1.65	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	47.46	6.06	1.01	4.04	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	58.01	6.92	1.73	1.34	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	54.27	6.12	0.42	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	46.99	6.93	3.34	4.11	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	50.55	7.26	2.42	3.39	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	50.70	7.33	3.87	2.04	1.83
chronic myelogenous leukemia cell line:K562	10454-106G4	78.91	17.08	1.77	1.77	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.79	9.38	1.30	1.04	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.94	1.60	0.91	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	18.22	9.02	1.39	0.52	0.35
colon carcinoma cell line:CACO-2	10513-107D9	71.39	17.76	4.94	1.65	0.73
colon carcinoma cell line:COLO-320	10420-106C6	35.35	2.66	0.76	1.14	0.76
colon, adult, donor1	10082-102B1	21.42	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	22.44	2.82	0.82	0.59	0.12
colon, fetal, donor1	10070-101I7	26.57	1.85	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	50.42	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	37.82	18.70	1.70	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	41.66	14.79	1.81	0.75	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	45.69	12.69	0.56	0.56	0.42
corpus callosum, adult, pool1	10042-101F6	21.45	1.77	0.55	0.33	0.44
cruciate ligament, donor2	10295-104G7	16.21	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	20.06	4.01	0.80	0.00	0.00
diencephalon, adult	10193-103E4	16.08	2.16	0.96	0.72	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.72	12.17	1.38	1.84	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	14.36	2.82	1.03	0.51	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.87	6.74	0.96	1.20	0.48
ductus deferens, adult	10196-103E7	17.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	4.32	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	27.22	3.68	1.47	0.74	0.74
dura mater, adult, donor1	10041-101F5	22.79	3.47	1.16	0.17	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	55.07	56.63	14.66	11.33	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	44.42	13.90	4.59	4.01	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	28.36	1.85	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	17.56	1.51	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	26.86	1.54	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	21.02	3.94	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	24.80	2.68	0.34	1.01	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	23.56	2.54	0.54	0.18	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	15.92	4.66	1.13	0.64	0.32
epidermoid carcinoma cell line:A431	10426-106D3	24.45	6.45	1.56	1.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	42.89	7.59	1.87	1.43	0.66
epididymis, adult	10197-103E8	16.12	2.51	0.00	0.63	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.18	1.06	0.71	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	10.62	2.75	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	46.00	4.59	1.70	1.18	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	51.28	6.00	1.08	1.67	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	50.53	5.27	1.23	1.12	0.11
esophagus, adult, pool1	10015-101C6	13.06	1.17	1.06	0.21	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.80	3.88	1.63	1.50	0.63
eye - muscle inferior rectus, donor1	10272-104E2	14.49	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	17.86	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	16.05	2.29	1.15	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	10.20	4.37	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	18.05	2.54	1.53	0.51	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	35.90	5.51	0.51	0.51	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	39.17	5.46	1.42	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	25.71	3.94	1.13	0.28	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	42.34	4.20	0.90	0.60	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	13.53	2.29	0.82	0.55	0.46
gall bladder, adult	10198-103E9	16.90	4.83	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	32.21	4.83	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	22.78	5.60	1.49	0.37	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	11.83	2.75	0.63	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.82	1.93	1.35	1.35	0.77
gastric cancer cell line:AZ521	10549-107H9	43.78	5.41	1.31	1.15	0.00
gastric cancer cell line:GSS	10560-108A2	35.69	3.66	2.75	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	33.58	13.25	1.60	1.83	0.23
giant cell carcinoma cell line:LU65	10487-107B1	28.57	2.64	2.87	2.41	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	29.95	2.66	2.38	0.70	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	25.94	2.24	0.75	0.75	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.97	8.13	0.53	0.74	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	40.87	6.60	1.40	0.56	0.14
glioblastoma cell line:T98G	10485-107A8	24.17	4.08	0.44	0.11	0.22
glioma cell line:GI-1	10413-106B8	15.82	5.27	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	26.24	1.46	4.37	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	21.24	1.71	2.69	0.00	0.98
globus pallidus, adult, donor10258	10367-105F7	21.91	2.74	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	13.32	4.26	3.73	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	61.18	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	20.91	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	16.32	2.56	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	58.77	9.18	5.97	3.21	0.46
hIPS +CCl2, biol_rep2	14384-156C1	40.24	11.89	4.12	3.20	0.00
hIPS +CCl2, biol_rep3	14385-156C2	43.80	12.24	6.44	1.29	0.00
hIPS, biol_rep1	14380-156B6	53.18	15.81	5.75	4.31	0.00
hIPS, biol_rep2	14381-156B7	42.52	11.66	1.37	1.37	2.06
hIPS, biol_rep3	14382-156B8	28.69	1.10	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.01	10.92	0.86	1.15	0.29
heart - mitral valve, adult	10205-103F7	13.15	1.79	0.00	1.20	0.60
heart - pulmonic valve, adult	10206-103F8	16.21	1.57	0.78	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	19.98	1.67	1.67	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	17.75	3.26	0.61	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	9.37	0.85	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	20.93	0.92	1.61	0.23	0.00
heart, fetal, pool1	10046-101G1	22.38	4.21	0.82	0.31	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	15.12	0.93	0.00	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	45.19	7.14	7.14	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	38.45	8.40	1.10	0.99	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	34.35	10.20	1.34	0.73	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	38.70	7.88	1.21	1.52	0.40
hepatoma cell line:Li-7	10484-107A7	48.60	7.12	1.45	1.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	44.32	11.66	1.91	1.91	0.70
hippocampus - adult, donor10196	10169-103B7	19.87	2.84	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	22.86	2.04	0.61	0.41	0.61
hippocampus, adult, donor10258	10374-105G5	18.92	2.49	1.99	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	15.51	2.47	3.88	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	51.27	18.92	14.04	5.49	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	32.40	6.28	4.52	1.77	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.04	8.89	6.60	2.79	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	28.19	5.64	2.26	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.53	3.87	0.52	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	25.43	4.93	2.28	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	23.36	8.47	4.67	0.88	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	22.62	4.31	2.59	1.08	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	23.36	5.84	2.09	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.20	8.76	1.42	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	33.59	9.64	1.29	1.61	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	29.63	9.43	1.35	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	27.23	9.23	6.89	2.50	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	39.30	10.81	6.88	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	32.29	34.04	8.73	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	27.68	3.63	1.53	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	30.53	3.92	1.74	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	33.98	6.50	3.50	2.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.39	4.33	7.16	0.38	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.46	4.09	3.18	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.67	5.01	6.26	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	19.92	6.04	0.98	0.98	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	20.32	8.42	1.74	1.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.94	7.77	1.49	2.39	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	33.44	10.35	3.88	2.03	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	41.65	9.98	3.71	1.71	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	44.51	17.97	8.17	4.49	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	33.10	4.93	2.11	1.06	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.66	3.17	0.63	0.32	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	27.54	4.24	1.82	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.72	5.69	1.55	1.55	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	17.27	3.32	1.99	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.01	3.85	2.82	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	19.94	4.09	2.30	1.28	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	21.96	5.30	2.27	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.56	6.05	2.02	1.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	33.09	9.42	4.11	0.48	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	34.32	10.25	5.35	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	40.00	14.63	4.39	1.95	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	22.62	4.28	2.14	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	58.56	55.31	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	27.80	4.63	1.32	1.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.99	4.93	2.74	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.27	3.26	3.62	1.45	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	18.86	3.56	2.85	1.07	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	4.77	1.19	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	31.69	7.58	2.57	2.03	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	24.25	4.85	1.08	0.54	0.54
immature langerhans cells, donor1	11904-125F5	27.12	20.34	0.73	0.48	0.24
immature langerhans cells, donor2	11905-125F6	23.76	10.30	1.58	1.58	0.00
insula, adult, pool1	10039-101F3	24.51	5.49	0.28	0.85	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	28.94	6.18	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	18.52	2.00	0.40	0.10	0.30
kidney, fetal, pool1	10045-101F9	14.93	2.69	1.84	0.28	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	22.30	2.70	0.57	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.43	1.24	0.41	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.51	3.67	2.20	0.37	0.00
left atrium, adult, donor1	10079-102A7	15.26	1.63	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	15.17	0.51	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	32.01	3.56	0.82	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	5.03	3.23	0.00	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	5.43	7.07	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	12.14	5.34	0.49	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	30.32	12.55	1.05	0.00	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	29.16	6.61	1.18	1.18	0.12
liposarcoma cell line:KMLS-1	10782-110G8	22.03	6.56	1.56	0.78	0.31
liposarcoma cell line:SW 872	10726-110A6	18.15	1.83	0.12	0.12	0.12
liver, adult, pool1	10018-101C9	14.59	0.97	0.32	0.00	0.00
liver, fetal, pool1	10086-102B5	8.47	1.88	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	17.06	2.62	1.17	0.00	0.58
locus coeruleus, adult, donor10252	10165-103B3	18.46	2.58	1.66	0.37	0.92
locus coeruleus, adult, donor10258	10375-105G6	17.77	3.10	1.13	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	15.56	3.79	3.36	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	15.22	1.94	0.83	0.69	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	26.89	3.45	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	23.33	2.77	0.66	0.79	0.13
lung, adult, pool1	10019-101D1	16.07	0.59	0.71	0.35	0.24
lung, fetal, donor1	10068-101I5	29.97	7.71	2.57	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	18.33	0.92	0.92	0.00	0.00
lymph node, adult, donor1	10077-102A5	23.19	2.84	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	34.19	6.36	0.44	1.10	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	71.39	20.07	2.57	1.51	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	21.24	7.65	0.85	4.25	0.00
mature adipocyte, donor1	12231-129F8	11.99	1.78	2.22	0.44	0.00
mature adipocyte, donor2	12232-129F9	15.56	2.91	1.87	1.87	0.83
mature adipocyte, donor3	12233-129G1	14.46	2.13	1.19	1.42	0.00
mature adipocyte, donor4	12234-129G2	18.16	3.69	2.37	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	22.87	2.62	1.43	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	28.20	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	21.88	3.49	1.84	0.55	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	31.45	3.18	1.59	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	22.18	13.65	10.24	1.71	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	29.87	5.91	0.84	0.51	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	23.77	2.97	1.06	0.64	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	0.00	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	20.10	8.61	3.59	3.23	0.36
medulla oblongata - adult, donor10196	10174-103C3	14.93	3.24	1.95	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	21.21	2.63	1.39	0.46	0.46
medulla oblongata, adult, pool1	10038-101F2	16.00	2.53	0.65	0.41	0.24
medulla oblongata, newborn, donor10223	10361-105F1	8.68	3.12	2.43	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	24.13	7.53	1.11	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	32.40	2.69	0.98	0.73	0.49
melanoma cell line:COLO 679	10514-107E1	16.96	1.58	0.43	1.29	0.14
melanoma cell line:G-361	10465-106H6	15.74	2.44	0.81	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	9.59	1.45	0.18	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	90.76	17.62	1.76	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	31.63	3.63	0.78	1.04	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.02	4.14	0.15	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.54	2.91	0.18	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	14.49	1.66	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	11.24	3.23	0.00	0.28	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.63	2.31	0.19	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.11	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.47	2.57	0.17	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.88	3.68	0.23	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	12.73	3.85	0.00	0.27	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.10	5.94	0.27	0.54	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	16.22	3.84	0.14	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.87	3.29	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	11.21	2.63	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	12.57	4.19	0.00	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	10.82	2.25	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	9.35	2.88	0.36	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.66	1.76	0.21	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.07	3.65	0.46	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	21.82	10.07	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	12.10	1.79	0.15	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	7.88	2.71	0.18	0.09	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	9.57	1.47	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	8.01	1.14	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	27.79	12.21	0.42	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.50	2.74	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.95	1.79	0.00	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	11.52	2.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	9.55	3.70	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.94	2.35	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.46	3.05	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.43	3.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	5.56	2.32	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	11.54	3.17	0.29	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.36	2.45	0.00	0.00	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.34	2.16	0.48	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.20	3.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	7.72	2.69	0.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	3.68	3.68	0.00	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	11.60	4.30	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	15.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.72	2.27	0.00	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	5.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	11.73	3.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.00	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	8.94	1.55	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	4.97	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.82	1.19	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	4.87	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.93	3.80	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	3.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.19	1.63	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.35	1.56	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	13.08	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.89	3.46	0.49	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	10.09	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	11.45	3.18	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.87	1.21	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.89	1.21	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.50	1.59	0.20	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	18.17	1.62	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	5.09	2.04	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.89	1.55	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	31.18	1.89	2.13	1.42	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	15.75	4.40	0.00	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	30.52	15.10	1.54	0.62	0.31
mesothelioma cell line:Mero-25	10850-111F4	24.74	8.17	2.27	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	34.23	5.62	0.98	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	23.47	10.63	1.33	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	21.55	7.62	0.00	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	20.43	6.64	0.68	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	18.45	3.79	0.76	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	16.56	6.63	0.62	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	13.42	4.97	0.33	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	31.67	17.74	1.63	1.27	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	15.54	4.10	0.51	0.00	0.17
mesothelioma cell line:NCI-H28	10845-111E8	27.74	5.09	2.04	1.02	0.76
mesothelioma cell line:No36	10857-111G2	26.10	8.48	0.98	0.98	0.65
mesothelioma cell line:ONE58	10858-111G3	31.70	13.82	1.35	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	12.09	2.69	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	12.33	1.95	0.00	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	14.54	2.33	0.54	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.47	1.31	0.33	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.64	4.45	0.21	1.70	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	54.83	6.45	2.53	0.00	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.54	5.14	0.19	0.95	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	56.36	7.95	1.85	0.55	0.18
myeloma cell line:PCM6	10474-106I6	22.34	1.78	0.00	0.00	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	28.92	4.57	0.00	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	5.69	0.98	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.03	0.67	1.34	0.45	0.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	11.40	1.03	1.25	0.74	0.15
nasal epithelial cells, donor2	12227-129F4	11.04	0.55	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	67.64	7.13	1.15	0.46	0.69
neuroblastoma cell line:NB-1	10539-107G8	56.50	10.29	1.50	1.50	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	33.53	2.95	1.48	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	42.86	8.01	2.42	0.56	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	18.27	3.32	0.00	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	28.03	3.96	0.48	0.63	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	24.15	2.62	0.60	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	18.44	1.91	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.37	2.13	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	122.95	24.69	1.18	0.85	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	35.22	6.40	2.40	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.14	4.81	0.32	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.04	3.68	0.00	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	22.68	2.81	0.56	0.28	0.19
occipital cortex - adult, donor10196	10172-103C1	30.91	2.06	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	19.59	2.15	2.42	0.00	0.81
occipital cortex, newborn, donor10223	10355-105E4	16.74	5.82	8.01	1.09	0.36
occipital lobe, adult, donor1	10076-102A4	20.73	2.10	0.26	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	36.04	3.00	3.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	18.29	2.05	0.24	0.24	0.08
olfactory region, adult	10195-103E6	12.61	2.10	0.19	0.19	0.38
optic nerve, donor1	10277-104E7	20.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.10	5.13	0.57	0.57	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	44.65	7.14	3.43	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.75	5.93	1.19	0.85	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.57	7.39	1.39	1.39	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	7.94	2.35	0.29	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	4.67	1.87	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	38.81	8.48	1.48	1.48	0.00
ovary, adult, pool1	10020-101D2	13.63	0.87	2.45	0.44	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.75	2.75	0.55	0.55	0.18
pancreas, adult, donor1	10049-101G4	15.05	0.94	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	32.71	2.80	0.56	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	14.99	4.94	0.34	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	22.68	6.29	0.33	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	22.06	3.02	0.37	0.09	0.27
parietal cortex, adult, donor10258	10373-105G4	11.01	0.00	0.73	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	14.11	5.64	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	17.67	2.28	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	19.47	3.44	0.88	0.09	0.26
parietal lobe, fetal, donor1	10072-101I9	39.76	3.88	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	17.57	8.97	4.86	2.99	1.12
parotid gland, adult	10199-103F1	18.50	1.85	0.62	0.00	0.00
penis, adult	10200-103F2	15.04	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	26.77	5.02	4.46	2.79	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.94	3.06	0.44	1.17	0.29
pineal gland - adult, donor10196	10179-103C8	12.26	4.52	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	34.35	3.55	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	12.54	1.25	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	29.34	4.05	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	38.05	4.17	3.65	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	31.50	3.40	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	19.24	0.97	1.08	0.32	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	28.47	11.52	1.72	1.19	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.52	2.18	0.47	0.16	0.47
pons, adult, pool1	10033-101E6	21.95	4.65	1.03	0.69	0.34
postcentral gyrus, adult, pool1	10032-101E5	20.66	3.49	0.26	0.44	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	10.46	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	47.49	3.20	0.87	1.46	0.44
prostate cancer cell line:PC-3	10439-106E7	45.92	3.09	0.18	0.54	0.54
prostate, adult, pool1	10022-101D4	14.42	1.18	0.27	0.27	0.27
putamen, adult, donor10196	10176-103C5	30.92	3.30	1.18	0.24	0.24
putamen, adult, donor10252	10152-102I8	11.76	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	19.67	7.65	3.28	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	13.29	0.48	0.48	0.24	0.48
putamen, newborn, donor10223	10365-105F5	13.49	6.75	3.00	2.25	0.75
rectal cancer cell line:TT1TKB	10469-106I1	29.68	2.91	2.04	0.87	0.29
rectum, fetal, donor1	10067-101I4	34.77	2.78	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	19.29	3.18	1.70	0.64	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.77	3.31	2.07	0.83	0.41
retina, adult, pool1	10030-101E3	16.80	2.48	0.80	0.00	0.89
retinoblastoma cell line:Y79	10475-106I7	81.06	10.39	2.34	1.82	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	28.65	2.46	0.74	0.86	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	35.71	1.69	3.37	0.56	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	8.34	1.52	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	10.20	4.05	0.00	0.00	0.00
salivary acinar cells, donor2	11772-123I8	10.46	5.23	0.14	0.28	0.00
salivary acinar cells, donor3	11773-123I9	7.28	1.32	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	24.59	2.86	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	26.98	4.55	0.51	0.42	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	30.56	4.23	0.12	0.24	0.35
seminal vesicle, adult	10201-103F3	20.63	0.53	1.06	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.09	6.07	0.97	1.70	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.83	3.52	0.25	0.50	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	23.08	4.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	20.01	4.70	1.61	1.61	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	19.45	3.65	0.88	0.33	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	30.97	6.71	0.52	0.65	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	45.40	2.84	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	23.63	2.16	0.84	0.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	23.12	3.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	22.09	2.52	1.89	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	63.37	7.00	2.67	1.33	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.35	14.18	0.95	0.95	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	39.32	4.24	1.35	0.77	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	44.01	5.77	0.82	0.82	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	27.83	4.34	5.15	0.48	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	28.33	5.45	1.09	0.00	0.22
small intestine, adult, pool1	10024-101D6	31.29	3.82	0.60	0.60	0.24
small intestine, fetal, donor1	10064-101I1	25.80	3.93	0.74	0.98	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	29.75	8.72	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	16.80	1.81	0.26	0.00	1.03
somatostatinoma cell line:QGP-1	10781-110G7	49.85	2.14	0.54	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	16.75	1.84	1.15	0.23	0.69
spinal cord, adult, donor10252	10159-103A6	25.23	2.76	2.37	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	15.91	4.84	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	26.83	4.27	0.00	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	15.15	5.51	0.92	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	18.67	1.64	0.15	0.00	0.00
spleen, adult, pool1	10025-101D7	22.25	2.31	0.33	0.00	0.00
spleen, fetal, pool1	10044-101F8	17.80	1.99	0.56	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	25.88	8.38	0.83	0.52	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	18.80	2.09	0.19	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	19.57	5.24	0.35	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.59	6.25	0.39	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	34.44	6.42	1.13	1.35	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.37	1.69	0.42	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	62.19	12.27	0.00	0.42	0.85
stomach, fetal, donor1	10062-101H8	58.74	2.14	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	17.09	1.71	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	21.39	1.66	2.08	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	16.03	2.07	0.52	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	12.72	1.41	2.12	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	71.30	10.09	1.60	0.92	1.83
temporal lobe, adult, pool1	10031-101E4	14.75	2.20	0.51	0.17	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	37.75	4.27	0.71	1.42	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	27.69	2.20	0.88	0.44	1.32
tenocyte, donor1	11763-123H8	9.43	3.14	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	6.87	1.53	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	8.15	1.11	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	124.41	15.30	5.61	7.82	1.53
teratocarcinoma cell line:NCR-G1	10798-110I6	74.15	20.66	6.17	2.77	0.77
teratocarcinoma cell line:PA-1	10807-111A6	50.99	7.28	2.79	0.62	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	41.77	6.86	2.54	1.78	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	35.55	3.78	2.27	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	26.39	3.82	1.74	0.55	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	34.85	5.21	5.54	1.63	0.98
testis, adult, pool1	10026-101D8	44.77	2.04	6.12	2.36	1.83
testis, adult, pool2	10096-102C6	66.31	5.86	8.12	5.41	2.26
thalamus - adult, donor10196	10168-103B6	27.60	2.21	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	25.32	2.03	2.97	1.09	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	3.08	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.36	0.99	0.33	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	9.21	6.33	2.30	0.00	0.00
throat, adult	10209-103G2	17.98	2.50	1.25	0.25	0.00
throat, fetal, donor1	10061-101H7	34.13	2.74	0.61	0.30	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	48.69	14.71	0.60	0.79	0.20
thymus, adult, pool1	10027-101D9	45.63	5.17	1.29	0.89	1.59
thymus, fetal, pool1	10043-101F7	43.43	5.20	2.08	1.35	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.66	3.06	0.80	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	37.16	6.01	1.54	0.98	0.00
thyroid, adult, pool1	10028-101E1	14.56	0.56	1.49	0.47	0.19
thyroid, fetal, donor1	10060-101H6	24.78	2.90	0.79	0.26	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	23.26	6.05	0.47	0.23	0.00
tongue, fetal, donor1	10059-101H5	28.77	2.76	0.79	0.39	0.39
tonsil, adult, pool1	10047-101G2	23.54	2.10	0.80	0.90	0.10
trachea, adult, pool1	10029-101E2	18.40	2.21	0.65	0.65	0.16
trachea, fetal, donor1	10058-101H4	21.54	1.54	0.38	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	21.26	5.67	0.35	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	27.66	5.07	0.61	0.61	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	19.12	2.19	0.63	0.47	0.16
tridermal teratoma cell line:HGRT	10694-109G1	19.03	3.81	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	19.72	3.89	0.17	0.34	0.00
umbilical cord, fetal, donor1	10057-101H3	8.35	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	19.11	2.05	0.85	0.34	0.34
uterus, fetal, donor1	10055-101H1	19.45	0.51	0.00	0.51	0.51
vagina, adult	10204-103F6	9.69	0.65	0.65	0.00	0.00
vein, adult	10191-103E2	18.19	2.19	0.66	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.22	8.28	0.80	1.07	0.53

Property "Nearest transcripts" (as page type) with input value "ENST00000645667.1:125 ENST00000640019.3:129 ENST00000378372.8:129 NM_001378790.1:129 NM_001378785.1:129 NM_016299.4:129 AK302452:139 AK225265:139 AK225651:139 AK000880:142 BC065281:152 BC038845:153 ENST00000493178.1:154 BC119690:164 BC119691:164 AF112210:164 AF143723:173 AK292323:175 KJ902567:225 AB528152:225 AB587406:225 KJ893846:225 ENST00000441647.1:260" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.